Loading...
XNAS
TLRY
Market cap823mUSD
Dec 05, Last price  
7.35USD
1D
1.80%
1Q
517.65%
IPO
-75.31%
Name

Tilray Inc

Chart & Performance

D1W1MN
XNAS:TLRY chart
P/E
P/S
0.73
EPS
Div Yield, %
Shrs. gr., 5y
54.71%
Rev. gr., 5y
23.58%
Revenues
1.13b
+4.84%
00443,7036,466,44715,171,30828,629,592175,247,597390,996,128513,085,000628,372,000627,124,0001,074,988,7001,126,991,996
Net income
-3.00b
L+798.92%
000305,1233,116,47622,837,28900-336,014,000-434,132,000-1,443,000,000-333,803,761-3,000,620,016
CFO
-95m
L+206.10%
00003,953,120000-44,717,000-177,262,0007,906,000-30,905,000-94,599,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
IPO date
Jul 19, 2018
Employees
1,600
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑052024‑052023‑052022‑052021‑052020‑052019‑052018‑052017‑052016‑05
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT